The latest price target for OrthoPediatrics (NASDAQ:KIDS) was reported by Canaccord Genuity on December 10, 2025. The analyst firm set a price target for $24.00 expecting KIDS to rise to within 12 months (a possible 34.30% upside). 20 analyst firms have reported ratings in the last year.

The latest analyst rating for OrthoPediatrics (NASDAQ:KIDS) was provided by Canaccord Genuity, and OrthoPediatrics initiated their buy rating.

There is no last upgrade for OrthoPediatrics

The last downgrade for OrthoPediatrics Corp happened on January 25, 2024 when Truist Securities changed their price target from $39 to $31 for OrthoPediatrics Corp.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of OrthoPediatrics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for OrthoPediatrics was filed on December 10, 2025 so you should expect the next rating to be made available sometime around December 10, 2026.

While ratings are subjective and will change, the latest OrthoPediatrics (KIDS) rating was a initiated with a price target of $0.00 to $24.00. The current price OrthoPediatrics (KIDS) is trading at is $17.87, which is within the analyst’s predicted range.